Skip to main content

Table 2 Predicted change from baseline in bladder diary variables after 12 weeks of treatment.

From: Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder

  Placebo Fesoterodine 4 mg Fesoterodine 8 mg
Micturitions per 24 hours -1.2 -1.7 -2.2
UUI episodes per 24 hours -1.1 -1.3 -1.4
MVV, mL 9.7 14.2* 28.4*
  1. MVV = mean voided volume; UUI = urgency urinary incontinence.
  2. *In addition to increase seen with placebo.